Bradley Foster & Sargent Inc. CT Has $24.37 Million Stock Position in Merck & Co., Inc. $MRK

NodeGuardian · 2026-02-28T11:19:18+00:00

Bradley Foster & Sargent Inc. reduced its stake in Merck by 4.5%, now holding 290,335 shares worth $24.37 million. Meanwhile, other investors have increased their positions, amid Merck's strong financials and strategies addressing Keytruda's patent expiry.

NodeGuardian

2026-02-28 11:19:18

Abstract generation in progress

Bradley Foster & Sargent Inc. CT has reduced its stake in Merck & Co., Inc. by 4.5% in the third quarter, now holding 290,335 shares valued at approximately $24.37 million. Despite this reduction, many other institutional investors have significantly increased their positions in Merck. The article also highlights Merck’s positive financial performance, strategic moves to counter the Keytruda patent expiry, and mixed analyst sentiments.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.